Aimcad Biotech was Established in 2001 as a result of the dedicated efforts put in by a team of committed professionals with strong determination to serve Humanity.
We strive to become a knowledge driven Pharmaceutical company with highest level of operational excellence in all spheres of life. Our core endeavors are to add value to customers and maximize the strength of customer relationships.

Aimcad Biotech since its incorporation has enhanced its competitive position in the pharma market through its focussed approach.

Aimcad Biotech is proud introducer of certain GMP certified Patent and Proprietary formulations.

Aimcad Biotech has a powerful element of social responsibility inscribed in its' values and its' concern for the society beyond its' business motives.

Alleviation of the sufferings of mankind, availability of the medicines to all at affordable price without any discrimination and continued efforts to improve the quality of the medicines, are our values and mission. The company's principal activity is manufacturing of Pharmaceutical products for multiple therapeautic fields.

Aimcad Biotech operates in total compliance with the GMP norms set by the W.H.O., Customer satisfaction has always drawn CPL strategies and attitudes. From the very beginning the company committed itself to supplying consumers with reliable medicaments, combining effectiveness, quality safety and competitive prices.

Aimcad Biotech is an established & experienced company marketing finished formulations & Personal care products. It currently has a highly skilled work force of dynamic persons.

Aimcad Biotech is a dynamic & a optimistic player in the pharma industry , having vision to create a truly international Pharma company that would address complete Pharma needs . The group is managed by the hardcore professionals of the Pharma industry & got the vast experience with unmatched expertise to achieve the strategic goals .

Aimcad Biotech is enjoying a very high reputation among the medical fraternity.

An organization’s capabilities and intent are strongly reflected in the products it manufactures. In other words, the manufacturing competencies and facilities should by echo truly, the R & D extent and the ability to implement it for the best of the market it targets. Our various manufacturing partners are certified by ISO 9001:2000, and WHO GMP standards.
Our manufacturing facilities confirm to the highest international standards and stringent guidelines as laid down by the World Health Organization current Good Manufacturing Practices, quality control, hygiene, safety, pollution control and environment friendly. Our manufacturing capacities facilitates the manufacturing of all kind of pharmaceutical formulations like tablets, capsules , dry powders, oral liquids, parenterals etc

Research and Development is a part of our strategy to become an integrated pharmaceutical industry. We believe R & D is of critical importance in our need to grow in the area of biotechnology and original drug research

The aim here is to devise formulations and dosage forms for new drugs to be introduced and to make variants of particular dosage forms. Another objective is to introduce drug combinations by understanding the mechanism of the interaction and the combined effects in increasing intensity of response , in decreasing untoward actions and in altering absorption.

The development of new delivery systems like nanoparticles and controlled drug delivery systems to ensure better compliance , less total drug, efficiency in treatment and economy.

Aimcad Biotech is driven by it Vision to achieve significant business in proprietary prescription products with a strong presence in the pharma market. Aimcad Biotech is eyeing upon better health achievement through effective and safe medicines based on technological innovation. Achieving customer satisfaction is fundamental to our business.

One of our key objectives has been to develop indigenous processes for new drugs introduced in the developed countries, produce and introduce them in lots of countries and promptly supply them to non-regulatory markets.